• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR Back to Search Results
Model Number 101967-750
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Skin Inflammation/ Irritation (4545)
Event Date 01/30/2022
Event Type  Injury  
Event Description
Senseonics was made aware of an incident where patient reported inflammation, redness and swelling at the insertion site.Upon informing the hcp about this, it was decided to extract the sensor because the insertion site was filled with pus.Hcp also told patient, that this inflammation is not caused by insertion (out of his experience), as time between insertion and inflammation is too long.User would like to get reinserted with another sensor to continue using eversense cgm system.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.No further investigation was necessary for this complaint.User went to hcp who decided to remove the sensor because of accumulation of pus at the insertion site.However, hcp mentioned that the inflammation was not due to insertion (based on his experience).User would make an appointment for another sensor insertion to continue using eversense cgm system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
IMPLANTABLE GLUCOSE MONITORING SYSTEM, SENSOR
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key19009380
MDR Text Key338980060
Report Number3009862700-2024-00323
Device Sequence Number1
Product Code QCD
UDI-Device Identifier00817491023360
UDI-Public817491023360
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/11/2021
Device Model Number101967-750
Device Catalogue NumberFG-4400-50-302
Device Lot NumberWP08230
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/31/2022
Initial Date FDA Received03/31/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/11/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-